Erratum: CXCR7 promotes pulmonary vascular remodeling via targeting p38/MMP2 pathway in pulmonary arterial hypertension
Erratum

Erratum: CXCR7 promotes pulmonary vascular remodeling via targeting p38/MMP2 pathway in pulmonary arterial hypertension

Editorial Office

Journal of Thoracic Disease

Correspondence to: Editorial Office. Journal of Thoracic Disease. Email: jtd@amepc.org.

Submitted Oct 12, 2025. Accepted for publication Nov 06, 2025. Published online Dec 29, 2025.

doi: 10.21037/jtd-2025b-13


Erratum to: J Thorac Dis 2024;16:2460-71.

In the article entitled “CXCR7 promotes pulmonary vascular remodeling via targeting p38/MMP2 pathway in pulmonary arterial hypertension” (1), an error was identified in Figure 3C.

The original Figure 3 is presented below:

The correct version of Figure 3, containing the correct data for the α-tubulin western blots in Figure 3C, is shown below.

The authors regretted the errors and confirmed they would not change the results or conclusions of the article.

Click here to view the updated version of the article.

Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/.


References

  1. Xu J, Miao S, Wu T, et al. CXCR7 promotes pulmonary vascular remodeling via targeting p38/MMP2 pathway in pulmonary arterial hypertension. J Thorac Dis 2024;16:2460-71. [Crossref] [PubMed]
Cite this article as: Editorial Office. Erratum: CXCR7 promotes pulmonary vascular remodeling via targeting p38/MMP2 pathway in pulmonary arterial hypertension. J Thorac Dis 2025;17(12):11531-11532. doi: 10.21037/jtd-2025b-13

Download Citation